scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0896-8411(05)80030-7 |
P698 | PubMed publication ID | 2252531 |
P2093 | author name string | Monreal M | |
Subirá ML | |||
Goñi F | |||
Yoldi A | |||
Oleaga A | |||
Goñi MJ | |||
Sevilla M | |||
Moncada E | |||
Sánchez-Ibarrola A | |||
Terán D | |||
P2860 | cites work | Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies | Q28237011 |
Direct evidence for loss of human suppressor cells during active autoimmune disease | Q35996534 | ||
Circulating thymic-hormone activity in congenital immunodeficiency | Q39450626 | ||
Multiple immunological abnormalities in patients with type 1 (insulin-dependent) diabetes mellitus | Q39768907 | ||
Protein glycosylation in diabetes mellitus: a review of laboratory measurements and of their clinical utility | Q40144848 | ||
Factors associated with early remission of type I diabetes in children treated with cyclosporine | Q41282880 | ||
Factors affecting and patterns of residual insulin secretion during the first year of type 1 (insulin-dependent) diabetes mellitus in children | Q42517345 | ||
Human interleukin 2. | Q43867352 | ||
Interleukin 1 dose-dependently affects the biosynthesis of (pro)insulin in isolated rat islets of Langerhans | Q43996137 | ||
Factors influencing the magnitude, duration, and rate of fall of B-cell function in type 1 (insulin-dependent) diabetic children followed for two years from their clinical diagnosis | Q44606337 | ||
Effects of Cyclosporine Immunosuppression in Insulin-Dependent Diabetes Mellitus of Recent Onset | Q49173574 | ||
Cyclosporin increases the rate and length of remissions in insulin-dependent diabetes of recent onset. Results of a multicentre double-blind trial. | Q53885179 | ||
IMMUNOLOGICAL FUNCTION OF THE THYMUS | Q56623510 | ||
Delineation of the Thymic and Bursal Lymphoid Systems in the Chicken | Q59068925 | ||
Radioimmunoassay of human proinsulin C-peptide using synthetic human connecting peptide | Q68778239 | ||
Immunosuppressive therapy in diabetes | Q69857709 | ||
Soluble immune response suppressor (SIRS) | Q69877871 | ||
Immunosuppression with azathioprine and prednisone in recent-onset insulin-dependent diabetes mellitus | Q70201930 | ||
Histiocytosis-X | Q70536356 | ||
P433 | issue | 5 | |
P921 | main subject | azathioprine | Q18939 |
immunotherapy | Q1427096 | ||
P304 | page(s) | 625-638 | |
P577 | publication date | 1990-10-01 | |
P1433 | published in | Journal of Autoimmunity | Q15716783 |
P1476 | title | Insulin requirements and residual beta-cell function 12 months after concluding immunotherapy in type I diabetic patients treated with combined azathioprine and thymostimulin administration for one year | |
P478 | volume | 3 |
Q41605577 | Autoimmune diabetes. The role of autoantibody markers in the prediction and prevention of insulin-dependent diabetes mellitus. |
Q40490594 | Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders |
Q38927961 | Immune-Modulating Therapy for Rheumatologic Disease: Implications for Patients with Diabetes |
Search more.